← All organizations
Highest phase reached
Phase 4
First clinical trial
Jun 1, 2015Last known activity
Aug 31, 2024
Acquired by IQVIA on Apr 1, 2021
Timeline
2010s
- Jun 1, 2015
Q2 solutions— Founded
2020s
- Apr 1, 2021
IQVIA— Acquired By
Drugs by trial phase (27 distinct, 17 trials)
Phase 4 (3 own, 0 via acquisition)
Phase 3 (7 own, 0 via acquisition)
Phase 2 (9 own, 0 via acquisition)
Phase 1 (7 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Recent trials (17)
- NCT06436911CollaboratorPhase 1/Phase 2Aug 31, 2024
- NCT05927649CollaboratorPhase 1Jul 11, 2023
- NCT05909644CollaboratorPhase 1Jul 5, 2023
- NCT05561764CollaboratorPhase 4Dec 31, 2022
- NCT05188729CollaboratorPhase 2Feb 1, 2022
- NCT05003310CollaboratorN/AOct 19, 2021
- NCT04731298CollaboratorPhase 2Apr 15, 2021
- NCT04145440CollaboratorPhase 1/Phase 2Oct 15, 2019
- NCT03815318CollaboratorPhase 3Jan 21, 2019
- NCT03526835CollaboratorPhase 1May 2, 2018
- NCT03460743CollaboratorPhase 3Mar 22, 2018
- NCT03321981CollaboratorPhase 2Jan 15, 2018
- NCT03202004CollaboratorPhase 3Aug 28, 2017
- NCT03184987CollaboratorPhase 3Jun 22, 2017
- NCT02725593CollaboratorPhase 3Jun 22, 2016
Details
- Founded
- Morrisville, NC, US Jun 1, 2015
- Last known activity
- Aug 31, 2024